Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

Big shakeups may be coming to the childhood vaccination schedule. Here's a look at some of the shots that could be subject to ...

The global Vaccines Market, valued at US$59.52 billion in 2024, stood at US$50.46 billion in 2025 and is projected to advance at a ...

We recently compiled a list of the 10 High Growth Pharma Stocks That Are Profitable in 2025. Merck & Co., Inc. stands third ...

Coupled with headwinds in China, Merck is also seeing lower demand for Gardasil in Japan. Sales are expected to remain weak in Japan in the second half of 2025. Our estimates for Gardasil sales ...

Real-world study data showed that the monoclonal antibody nirsevimab was highly effective at preventing severe respiratory ...

ACOG released updated clinical guidance on vaccination for COVID-19, respiratory syncytial virus and influenza during ...

With the approach of fall likely bringing the usual uptick in respiratory illness, the provincial government is boosting its range of protections against RSV, with free vaccines available for more ...

The Manitoba government plans on updating its RSV immunization program this fall, but the province is not committing to following the majority of Canada in extending the preventative treatment to ...

Background: Respiratory Syncytial Virus (RSV) poses a major health threat to older adults, pregnant women, and high-risk populations. We systematically evaluated the efficacy, immunogenicity, and ...